Answers are grounded in this paper and cite their sources.
Huseyin Naci and colleagues find that raising evidence standards for market entry of new drugs could have numerous benefits, including providing incentives for development in therapeutic areas with few treatment options
No takes yet. Share an insight, caveat, or question.
Naci et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: